Abstract

In these experiments we examined whether the elevations in intracellular Ca2+concentration ([Ca2+]i) induced by methylmercury (MeHg) (described in our previous study) might contribute to cerebellar granule cell mortality following exposure to MeHgin vitro.Cells were exposed to 0.5 μM MeHg for 45 min or 1 μM MeHg for 38 min, conditions previously shown to induce elevations in [Ca2+]iin these cells. Control cells were exposed to buffer alone for 60 min. Viability was assessed using the Live/Dead viability/cytotoxicity kit. At 30 min post-MeHg exposure, there was no immediate increase in cell mortality; however, by 3.5 h after the onset of MeHg exposure, cell viability decreased to 74 and 54% of control values for 0.5 and 1.0 μM MeHg, respectively. At 24.5 h after MeHg exposure, cell viability declined to approximately 27%. Losses in cell viability at 3.5 h were prevented by pretreating the granule cells for 65 min with the Ca2+chelator 1,2-bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid tetrakis(acetoxymethyl)ester (BAPTA; 10 μM), then exposing the cells to MeHg in the continued presence of BAPTA; however, at 24.5 h, BAPTA no longer prevented MeHg-induced cell death. Exposure to the Ca2+channel blockers ω-conotoxin MVIIC (1 μM) or nifedipine (1 μM), previously shown to delay elevations in [Ca2+]iwith MeHg exposurein vitro,protected granule cells from MeHg-induced mortality at 3.5 h postexposure. These data suggest that at early time points, MeHg-induced increases in [Ca2+]imay contribute to granule cell mortality; however, the role of Ca2+at later time points is unclear.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call